Fig. 4
From: The effect of azithromycin on sputum inflammatory markers in bronchiectasis
Association between baseline inflammatory profile and the effect of AZM maintenance treatment on change in lung function in bronchiectasis. Forest plot; data are presented as Δ FEV1% of predicted (End-Start) with 95% CI. X-axis: Increase in FEV1% of predicted during 1-year AZM treatment. Y-axis: The + or – represent respectively values above or below the median of the specific inflammatory marker at baseline